Nuclear Medicine Europe’s white paper examining the role of dosimetry in therapeutic radiopharmaceuticals (tRPs).
The paper addresses ongoing debate within the nuclear medicine community about whether individual dosimetry should be compulsory in clinical practice.
The paper calls for a coherent regulatory framework that recognizes the specificities of tRPs and emphasizes the need for multistakeholder dialogue to ensure guidelines remain both fit for purpose and future proof as this field continues to evolve.